Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Pharma & Biotech

Milestone Scientific expands sales in Texas as UTMB Health Clear Lake Campus Hospital begins using CompuFlo epidural instrument

UTMB is a major academic health sciences center of global influence and the move comes after the MedTech group began selling CompuFlo disposables previously to the UTMB Health Galveston Campus Hospital

Milestone Scientific Inc (NYSE:MLSS) has expanded sales of its equipment in Texas, saying that the University of Texas Medical Branch (UTMB) Health Clear Lake Campus Hospital has now begun using its CompuFlo Epidural Instrument.

UTMB is a major academic health sciences center of global influence and the move comes after the MedTech group began selling CompuFlo disposables previously to the UTMB Health Galveston Campus Hospital.

READ: Milestone Scientific expands sales team to capitalize on interest in CompuFlo and CathCheck medical devices

"I am very pleased to announce that UTMB Health has expanded its use of the CompuFlo Epidural Instrument, including its consumables to its Clear Lake Campus Hospital," said Arjan Haverhals, CEO of Milestone Scientific.

"This expansion follows successful use of the instrument and disposables at the Galveston Campus Hospital and is strong validation of the favorable response to our technology by leading anesthesiologists. At the same time, our new sales force initiatives are taking hold, and interest in the technology is growing."

Milestone Scientific patents, designs and develops innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications.

The firm's computer-controlled systems are designed to make injections precise, efficient, and virtually painless, and its CompuFlo product for epidural injections has a 99% success in locating the epidural space on the first attempt. Done manually, the procedure can be cumbersome and time-consuming.

At the end of last month, the company boosted its medical sales team with the appointment of Chet Trechock as vice president of sales medical along with three new representatives.

Contact the author at giles@proactiveinvestors.com

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK